Cytokinetics Inc (CYTK) — 10-Q Filings
All 10-Q filings from Cytokinetics Inc. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Cytokinetics' Q3 Loss Widens on Debt Conversion, R&D Spikes
— Nov 5, 2025 Risk: high
CYTOKINETICS INC reported a significant increase in net loss for the three months ended September 30, 2025, reaching $306.178 million, up from $160.545 million -
Cytokinetics Files Q1 2025 10-Q, Details Financials
— May 6, 2025 Risk: medium
Cytokinetics Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial performance and business activities, including deta -
Cytokinetics Q3 2024 Update: Notes, Loans, and R&D
— Nov 7, 2024 Risk: medium
Cytokinetics Inc. reported its third quarter 2024 results, ending September 30, 2024. The company's financial filings indicate ongoing research and development -
Cytokinetics Files 10-Q Amidst Public Offering and Loan Amendments
— Aug 9, 2024 Risk: medium
Cytokinetics Inc. filed its 10-Q for the period ending June 30, 2024. The company reported on its financial performance and ongoing research and development act -
Cytokinetics, Inc. Files 10-Q for Period Ending March 31, 2024
— May 10, 2024 Risk: medium
CYTOKINETICS INC (CYTK) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Cytokinetics, Inc. filed a 10-Q report for the period ending March 31, 202
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX